Drug
Rsvpref
Rsvpref: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| RSVpreF NCT07839871 | Phase 3 | Respiratory Syncytial Virus (RSV) |
Latest
No recent events.
Follow Rsvpref on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.